Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer

Nohelia Cajas-Salazar; William W. Au; Joseph B. Zwischenberger; Carlos H. Sierra-Torres; Salama A. Salama; Scott K. Alpard; Stephen K. Tyring

doi:10.1016/S0165-4608(03)00058-X

Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer

Nohelia Cajas-Salazar
, William W. Au
, Joseph B. Zwischenberger
, Carlos H. Sierra-Torres
, Salama A. Salama
, Scott K. Alpard
, Stephen K. Tyring

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Abstract

Microsomal epoxide hydrolase (mEH) gene is polymorphic and its enzyme is involved in the activation and subsequent detoxification of several tobacco carcinogens, for example polycyclic aromatic hydrocarbons. Therefore, we have investigated the association of two polymorphisms at exons 3 and 4 of the mEH gene with the development of lung cancer in 110 patients and 119 matched controls. In addition, we have investigated the relationship between the different mEH alleles and the frequency of chromosome aberrations (CA), as an approach to understand the role of genetic susceptibility on cancer risk. Our results show that only the homozygous exon 4 fast genotype is significantly associated with increased risk for lung cancer (odds ratio [OR] = 6.26; 95% confidence interval [CI] = 1.02-38.3). When the exons 3 and 4 polymorphisms are considered together, patients carrying the high enzyme activity genotype have a significantly increased risk for lung cancer (OR = 2.46; 95% CI = 1.06-5.68). More importantly, the increased risk for this group is confirmed by their having the highest frequency of CA compared to any other genotype groups. In addition, genotypes with higher risk had consistently more CA than those with lower risk. Our CA data also indicates that the low activity genotype may exert a protective role in cigarette smokers, as it was associated with a significant decrease in CA compared to the high and intermediate activity genotypes. In conclusion, the CA data provides evidence to support that susceptibility mEH alleles are significantly involved with the development of lung cancer from cigarette smoking.

Original language	English
Pages (from-to)	97-102
Number of pages	6
Journal	Cancer Genetics and Cytogenetics
Volume	145
Issue number	2
DOIs	https://doi.org/10.1016/S0165-4608(03)00058-X
State	Published - Sep 2003

Bibliographical note

Funding Information:
This study was partially supported by a grant from the NIEHS Center Grant (no. ES06676) to the University of Texas Medical Branch (UTMB) and Colciencias-Fulbright-LASPAU fellowships to N.C.S. and to C.H.S.T. The study utilized services from the General Clinical Research Center (GCRC) with funding from the National Center for Research Resources (no. M01 RR-00073), and services from the Molecular Biology Core of the NIEHS Center, both at UTMB. The authors express their appreciation to Dr. David Eastmond from the University of California at Irvine for providing us with the classical probe for the FISH assay, Dr. Andrew Wyrobek and his student Eddy Sloter from the Lawrence Livermore National Laboratory for the technical advice, and the UTMB's staff in the various clinics and offices for their support.

Funding

This study was partially supported by a grant from the NIEHS Center Grant (no. ES06676) to the University of Texas Medical Branch (UTMB) and Colciencias-Fulbright-LASPAU fellowships to N.C.S. and to C.H.S.T. The study utilized services from the General Clinical Research Center (GCRC) with funding from the National Center for Research Resources (no. M01 RR-00073), and services from the Molecular Biology Core of the NIEHS Center, both at UTMB. The authors express their appreciation to Dr. David Eastmond from the University of California at Irvine for providing us with the classical probe for the FISH assay, Dr. Andrew Wyrobek and his student Eddy Sloter from the Lawrence Livermore National Laboratory for the technical advice, and the UTMB's staff in the various clinics and offices for their support.

Funders	Funder number
Colciencias-Fulbright-LASPAU
NIEHS Center
National Institutes of Health/National Institute of Environmental Health Sciences	P30ES006676
National Institutes of Health/National Institute of Environmental Health Sciences
National Center for Research Resources	M01 RR-00073
National Center for Research Resources
University of Texas Medical Branch

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Molecular Biology
Genetics
Cancer Research

Access to Document

10.1016/S0165-4608(03)00058-X

Cite this

@article{7e9df23a80564bff86fe1f9457159f2a,

title = "Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer",

abstract = "Microsomal epoxide hydrolase (mEH) gene is polymorphic and its enzyme is involved in the activation and subsequent detoxification of several tobacco carcinogens, for example polycyclic aromatic hydrocarbons. Therefore, we have investigated the association of two polymorphisms at exons 3 and 4 of the mEH gene with the development of lung cancer in 110 patients and 119 matched controls. In addition, we have investigated the relationship between the different mEH alleles and the frequency of chromosome aberrations (CA), as an approach to understand the role of genetic susceptibility on cancer risk. Our results show that only the homozygous exon 4 fast genotype is significantly associated with increased risk for lung cancer (odds ratio [OR] = 6.26; 95\% confidence interval [CI] = 1.02-38.3). When the exons 3 and 4 polymorphisms are considered together, patients carrying the high enzyme activity genotype have a significantly increased risk for lung cancer (OR = 2.46; 95\% CI = 1.06-5.68). More importantly, the increased risk for this group is confirmed by their having the highest frequency of CA compared to any other genotype groups. In addition, genotypes with higher risk had consistently more CA than those with lower risk. Our CA data also indicates that the low activity genotype may exert a protective role in cigarette smokers, as it was associated with a significant decrease in CA compared to the high and intermediate activity genotypes. In conclusion, the CA data provides evidence to support that susceptibility mEH alleles are significantly involved with the development of lung cancer from cigarette smoking.",

author = "Nohelia Cajas-Salazar and Au, \{William W.\} and Zwischenberger, \{Joseph B.\} and Sierra-Torres, \{Carlos H.\} and Salama, \{Salama A.\} and Alpard, \{Scott K.\} and Tyring, \{Stephen K.\}",

note = "Funding Information: This study was partially supported by a grant from the NIEHS Center Grant (no. ES06676) to the University of Texas Medical Branch (UTMB) and Colciencias-Fulbright-LASPAU fellowships to N.C.S. and to C.H.S.T. The study utilized services from the General Clinical Research Center (GCRC) with funding from the National Center for Research Resources (no. M01 RR-00073), and services from the Molecular Biology Core of the NIEHS Center, both at UTMB. The authors express their appreciation to Dr. David Eastmond from the University of California at Irvine for providing us with the classical probe for the FISH assay, Dr. Andrew Wyrobek and his student Eddy Sloter from the Lawrence Livermore National Laboratory for the technical advice, and the UTMB's staff in the various clinics and offices for their support.",

year = "2003",

month = sep,

doi = "10.1016/S0165-4608(03)00058-X",

language = "English",

volume = "145",

pages = "97--102",

number = "2",

}

TY - JOUR

T1 - Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer

AU - Cajas-Salazar, Nohelia

AU - Au, William W.

AU - Zwischenberger, Joseph B.

AU - Sierra-Torres, Carlos H.

AU - Salama, Salama A.

AU - Alpard, Scott K.

AU - Tyring, Stephen K.

N1 - Funding Information: This study was partially supported by a grant from the NIEHS Center Grant (no. ES06676) to the University of Texas Medical Branch (UTMB) and Colciencias-Fulbright-LASPAU fellowships to N.C.S. and to C.H.S.T. The study utilized services from the General Clinical Research Center (GCRC) with funding from the National Center for Research Resources (no. M01 RR-00073), and services from the Molecular Biology Core of the NIEHS Center, both at UTMB. The authors express their appreciation to Dr. David Eastmond from the University of California at Irvine for providing us with the classical probe for the FISH assay, Dr. Andrew Wyrobek and his student Eddy Sloter from the Lawrence Livermore National Laboratory for the technical advice, and the UTMB's staff in the various clinics and offices for their support.

PY - 2003/9

Y1 - 2003/9

N2 - Microsomal epoxide hydrolase (mEH) gene is polymorphic and its enzyme is involved in the activation and subsequent detoxification of several tobacco carcinogens, for example polycyclic aromatic hydrocarbons. Therefore, we have investigated the association of two polymorphisms at exons 3 and 4 of the mEH gene with the development of lung cancer in 110 patients and 119 matched controls. In addition, we have investigated the relationship between the different mEH alleles and the frequency of chromosome aberrations (CA), as an approach to understand the role of genetic susceptibility on cancer risk. Our results show that only the homozygous exon 4 fast genotype is significantly associated with increased risk for lung cancer (odds ratio [OR] = 6.26; 95% confidence interval [CI] = 1.02-38.3). When the exons 3 and 4 polymorphisms are considered together, patients carrying the high enzyme activity genotype have a significantly increased risk for lung cancer (OR = 2.46; 95% CI = 1.06-5.68). More importantly, the increased risk for this group is confirmed by their having the highest frequency of CA compared to any other genotype groups. In addition, genotypes with higher risk had consistently more CA than those with lower risk. Our CA data also indicates that the low activity genotype may exert a protective role in cigarette smokers, as it was associated with a significant decrease in CA compared to the high and intermediate activity genotypes. In conclusion, the CA data provides evidence to support that susceptibility mEH alleles are significantly involved with the development of lung cancer from cigarette smoking.

AB - Microsomal epoxide hydrolase (mEH) gene is polymorphic and its enzyme is involved in the activation and subsequent detoxification of several tobacco carcinogens, for example polycyclic aromatic hydrocarbons. Therefore, we have investigated the association of two polymorphisms at exons 3 and 4 of the mEH gene with the development of lung cancer in 110 patients and 119 matched controls. In addition, we have investigated the relationship between the different mEH alleles and the frequency of chromosome aberrations (CA), as an approach to understand the role of genetic susceptibility on cancer risk. Our results show that only the homozygous exon 4 fast genotype is significantly associated with increased risk for lung cancer (odds ratio [OR] = 6.26; 95% confidence interval [CI] = 1.02-38.3). When the exons 3 and 4 polymorphisms are considered together, patients carrying the high enzyme activity genotype have a significantly increased risk for lung cancer (OR = 2.46; 95% CI = 1.06-5.68). More importantly, the increased risk for this group is confirmed by their having the highest frequency of CA compared to any other genotype groups. In addition, genotypes with higher risk had consistently more CA than those with lower risk. Our CA data also indicates that the low activity genotype may exert a protective role in cigarette smokers, as it was associated with a significant decrease in CA compared to the high and intermediate activity genotypes. In conclusion, the CA data provides evidence to support that susceptibility mEH alleles are significantly involved with the development of lung cancer from cigarette smoking.

UR - https://www.scopus.com/pages/publications/0043165103

UR - https://www.scopus.com/pages/publications/0043165103#tab=citedBy

U2 - 10.1016/S0165-4608(03)00058-X

DO - 10.1016/S0165-4608(03)00058-X

M3 - Article

C2 - 12935919

AN - SCOPUS:0043165103

SN - 0165-4608

VL - 145

SP - 97

EP - 102

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

IS - 2

ER -

Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer

Abstract

Bibliographical note

Funding

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this